ClinicalTrials.Gov: Confidentiality Concerns Are Decreasing, PhRMA Says

Pharmaceutical manufacturers are becoming more comfortable with the disclosures required on ClinicalTrials.gov as they become more familiar with the system, Pharmaceutical Research & Manufacturers of America Associate VP-Regulatory Affairs Alan Goldhammer, PhD, reports

More from Archive

More from Pink Sheet